RIVASTIGMINE TARTRATE
Generic: RIVASTIGMINE TARTRATE
Dr. Reddy's Laboratories LimitedManufacturer
ORALRoute
RIVASTIGMINE TARTRATEActive Substance
2007-10-31Original Approval
RIVASTIGMINE TARTRATE is FDA application ANDA077130, sponsored by DR REDDYS LABS INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class III2017-03-06
RIVASTIGMINE Tartrate Capsules, USP, 1.5 mg, 60-count bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, BachupCross-contamination with other products -Related Substances test for Rivastigmine Tartrate Capsules
Class II2015-08-03
Rivastigmine Tartrate Capsules, USP 1.5 mg, 60 count bottle, Rx Only, Mfd. By Dr. Reddy's Laboratories Limited, BachupalFailed Dissolution Specifications
Top Reported Reactions
1
DRUG INTERACTION
54 reports
2
FALL
51 reports
3
CONFUSIONAL STATE
43 reports
4
ANTICHOLINERGIC SYNDROME
42 reports
5
DEATH
41 reports
6
NAUSEA
33 reports
7
HALLUCINATION
31 reports
8
VOMITING
30 reports
9
DRUG INEFFECTIVE
29 reports
10
DIARRHOEA
27 reports